Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 21, 48-51, January 1, 1961]
© 1961 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Colter, J. S.
Right arrow Articles by Ellem, K. A. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Colter, J. S.
Right arrow Articles by Ellem, K. A. O.

The Ribonucleases of Mouse Ascites Tumors*

J. S. Colter, Jeanne Kuhn and K. A. O. Ellem{dagger}

( Wistar Institute of Anatomy and Biology, Philadelphia, Pa.)

The ribonuclease activities of seven ascites tumors of mice have been studied. Homogenates of all tumors exhibited two apparent activity optima—one between pH 4.7 and 5.4, the other between pH 8.5 and 9.3. These two values are outside the range in which normal tissues have optimal activity.

In the presence of p-chloromercuribenzoate, these two optima disappeared and were replaced by a single peak at a pH of 7.0–7.3, suggesting that the two optima seen in the absence of p-chloromercuribenzoate result from the dissociation of an enzyme-inhibitor complex.

A ribonuclease inhibitor has been isolated from Ehrlich ascites tumor cells and shown to inhibit bovine pancreatic ribonuclease. An investigation of the effect of pH on the inhibition of the crystalline enzyme by the tumor cell inhibitor has provided data which support the premise that the two optima obtained with tumor cell homogenates in the normal assay system are due to dissociation of an enzyme-inhibitor complex.

* Supported by grants from the National Institutes of Health (C-4534 and 2G-142-C1), the American Cancer Society (E-89), and the Samuel S. Fels Fund.

{dagger} Travelling Fellow of the New South Wales State Cancer Council.

Received 7/18/60.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1961 by the American Association for Cancer Research.